title: [Resting heart rate: how to use it for cardiovascular prevention?].
abstract: Resting heart rate is a very accessible clinical parameter in medical practice. Several observational studies have described the link between resting heart rate and the risk of cardiovascular events. An elevated resting heart rate was associated with an increased risk of heart failure and cardiovascular mortality, independently of cardiovascular risk factors. By contrast, interventional studies have shown that reducing heart rate with drugs was beneficial only in patients with pre-existing heart failure or those with coronary heart disease. We aim to review the role and implications of resting heart rate for cardiovascular prevention.
authors.forename: Marine
authors.initials: M
authors.lastname: Fassbind
authors.forename: Patrick
authors.initials: P
authors.lastname: Yerly
authors.forename: David
authors.initials: D
authors.lastname: Nanchen
mesh_terms: D058671:Adrenergic beta-1 Receptor Antagonists / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control*; D006333:Heart Failure / Q000517:prevention & control; D006339:Heart Rate; D006801:Humans; D064887:Observational Studies as Topic; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012146:Rest; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D058671:Adrenergic beta-1 Receptor Antagonists